Evidence map›Paper›PMID 26646950›Full record

ArticleClinical and experimental immunology2016

Interleukin-21 induces migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis.

R Xing, Y Jin, L Sun, L Yang, C Li, Z Li, X Liu, J Zhao

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Platelet-rich Plasma: ACurrent drug research reviews · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

R XingDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, PR China.
Y JinDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, PR China.
L SunDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, PR China.
L YangDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, PR China.
C LiDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, PR China.
Z LiDepartment of Anesthesiology, Peking University Third Hospital, Beijing, PR China.
X LiuDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, PR China.
J ZhaoDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, PR China.
Peking University Third Hospital · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial fibroblast hyperplasia and bone erosion. Fibroblast-like synoviocytes (FLS) play a pivotal role in RA pathogenesis through aggressive migration and matrix invasion, and certain proinflammatory cytokines may affect synoviocyte invasion. Whether interleukin (IL)-21 influences this process remains controversial. Here, we evaluated the potential regulatory effect of IL-21 on the migration, invasion and matrix metalloproteinase (MMP) expression in RA-FLS. We found that IL-21 promoted the migration, invasion and MMP (MMP-2, MMP-3, MMP-9, MMP-13) production in RA-FLS. Moreover, IL-21 induced activation of the phosphoinositide 3-kinase (PI3K), signal transducer and activator of transcription-3 (STAT-3) and extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) pathways, and blockage of these pathways [PI3K/protein kinase B (AKT) inhibitor LY294002, STAT-3 inhibitor STA-21 and ERK1/2 inhibitor PD98059] attenuated IL-21-induced migration and secretion of MMP-3 and MMP-9. In conclusion, our results suggest that IL-21 promotes migration and invasion of RA-FLS. Therefore, therapeutic strategies targeting IL-21 might be effective for the treatment of RA.

Indexed as

AdultAgedArthritis, RheumatoidCadherinsCD4-Positive T-LymphocytesCell MovementCells, CulturedChromonesEnzyme ActivationEnzyme-Linked Immunosorbent AssayExtracellular Signal-Regulated MAP KinasesFemaleFibroblastsFlavonoidsHumansIntercellular Adhesion Molecule-12-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneCadherinsChromonesExtracellular Signal-Regulated MAP KinasesFlavonoidsICAM1 protein, humanIntercellular Adhesion Molecule-1Interleukin-21InterleukinsMatrix Metalloproteinase 13Matrix Metalloproteinase 2Matrix Metalloproteinase 3Matrix Metalloproteinase 9MMP13 protein, humanMMP2 protein, humanMMP3 protein, humanMMP9 protein, humanMorpholinesosteoblast cadherinPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPolycyclic CompoundsSTA-21STAT3 protein, humanSTAT3 Transcription Factorfibroblast-like synoviocytesinterleukin-21invasionmatrix metalloproteinasesmigration

Identifiers

PMID26646950
PMCPMC4837236
OpenAlexW2190613537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.